Effect of achieved hemoglobin level on renal outcome in non-dialysis chronic kidney disease (CKD) patients receiving epoetin beta pegol: MIRcerA CLinical Evidence on Renal Survival in CKD patients with renal anemia (MIRACLE-CKD Study)

BACKGROUND: Previous randomized-controlled trials have shown that targeting higher hemoglobin (Hb) levels using high dose of ESA in non-dialysis chronic kidney disease (NDCKD) patients resulted in poorer cardiovascular outcome; however, it remains unknown how high Hb levels achieved by ESA in clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayashi, Terumasa, Uemura, Yukari, Kumagai, Michiko, Kimpara, Masashi, Kanno, Hiroyuki, Ohashi, Yasuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394571/
https://www.ncbi.nlm.nih.gov/pubmed/30291472
http://dx.doi.org/10.1007/s10157-018-1649-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394571/
https://www.ncbi.nlm.nih.gov/pubmed/30291472
http://dx.doi.org/10.1007/s10157-018-1649-0

Ejemplares similares